116 related articles for article (PubMed ID: 12689511)
1. Dibucaine inhibition of serum cholinesterase.
Elamin B
J Biochem Mol Biol; 2003 Mar; 36(2):149-53. PubMed ID: 12689511
[TBL] [Abstract][Full Text] [Related]
2. The hydrolysis of succinyldithiocholine and related thiocholine esters by human plasma and purified cholinesterase.
Wetherell JR; French MC
Biochem Pharmacol; 1986 Mar; 35(6):939-45. PubMed ID: 3954797
[TBL] [Abstract][Full Text] [Related]
3. An explanation for the different inhibitory characteristics of human serum butyrylcholinesterase phenotypes deriving from inhibition of atypical heterozygotes.
Simeon-Rudolf V; Kovarik Z; Skrinjarić-Spoljar M; Evans RT
Chem Biol Interact; 1999 May; 119-120():159-64. PubMed ID: 10421449
[TBL] [Abstract][Full Text] [Related]
4. MEASUREMENT OF HYDROLYSIS OF ACETYLTHIOCHOLINE WITH THE SILVER THIOL ELECTRODE. ITS USE IN THE STUDY OF SERUM PSEUDOCHOLINESTERASE INHIBITION.
CURTAIN CC
Anal Biochem; 1964 Jun; 8():184-91. PubMed ID: 14186673
[No Abstract] [Full Text] [Related]
5. Scope and limitations of propionylthiocholinesterase in the characterisation of cholinesterase variants.
Price EM; Brown SS
Clin Biochem; 1975 Dec; 8(6):384-90. PubMed ID: 1204213
[TBL] [Abstract][Full Text] [Related]
6. An improvement in segregation of human butyrylcholinesterase phenotypes having the fluoride-resistant variants.
Kovarik Z; Simeon-Rudolf V
Arh Hig Rada Toksikol; 2003 Dec; 54(4):239-44. PubMed ID: 14994645
[TBL] [Abstract][Full Text] [Related]
7. Reversible inhibition of acetylcholinesterase and butyrylcholinesterase by 4,4'-bipyridine and by a coumarin derivative.
Simeon-Rudolf V; Kovarik Z; Radić Z; Reiner E
Chem Biol Interact; 1999 May; 119-120():119-28. PubMed ID: 10421445
[TBL] [Abstract][Full Text] [Related]
8. alpha,beta-Dehydrophenylalanine choline esters, a new class of reversible inhibitors of human acetylcholinesterase and butyrylcholinesterase.
Grigoryan HA; Hambardzumyan AA; Mkrtchyan MV; Topuzyan VO; Halebyan GP; Asatryan RS
Chem Biol Interact; 2008 Jan; 171(1):108-16. PubMed ID: 17980356
[TBL] [Abstract][Full Text] [Related]
9. Anionic site interactions in human butyrylcholinesterase disrupted by two single point mutations.
Neville LF; Gnatt A; Padan R; Seidman S; Soreq H
J Biol Chem; 1990 Dec; 265(34):20735-8. PubMed ID: 2249982
[TBL] [Abstract][Full Text] [Related]
10. Concordance of butyrylcholinesterase phenotype with genotype: implications for biochemical reporting.
Parnas ML; Procter M; Schwarz MA; Mao R; Grenache DG
Am J Clin Pathol; 2011 Feb; 135(2):271-6. PubMed ID: 21228368
[TBL] [Abstract][Full Text] [Related]
11. Determination of serum cholinesterase activity and dibucaine numbers by an amperometric choline sensor.
Palleschi G; Lavagnini MG; Moscone D; Pilloton R; D'Ottavio D; Evangelisti ME
Biosens Bioelectron; 1990; 5(1):27-35. PubMed ID: 2178637
[TBL] [Abstract][Full Text] [Related]
12. Horse serum butyrylcholinesterase kinetics: a molecular mechanism based on inhibition studies with dansylaminoethyltrimethylammonium.
Cauet G; Friboulet A; Thomas D
Biochem Cell Biol; 1987 Jun; 65(6):529-35. PubMed ID: 3426832
[TBL] [Abstract][Full Text] [Related]
13. Serum pseudocholinesterase and dibucaine numbers as measured with the Technicon RA-1000 analyzer.
Rostron P; Higgins T
Clin Chem; 1988 Sep; 34(9):1924-5. PubMed ID: 3416461
[No Abstract] [Full Text] [Related]
14. Interactions of human butyrylcholinesterase with phenylvalerate and acetylthiocholine as substrates and inhibitors: kinetic and molecular modeling approaches.
Estévez J; Rodrigues de Souza F; Romo M; Mangas I; Costa Franca TC; Vilanova E
Arch Toxicol; 2019 May; 93(5):1281-1296. PubMed ID: 30877329
[TBL] [Abstract][Full Text] [Related]
15. Frequency of butyrylcholinesterase gene mutations in individuals with abnormal inhibition numbers: an Italian-population study.
Lando G; Mosca A; Bonora R; Azzario F; Penco S; Marocchi A; Panteghini M; Patrosso MC
Pharmacogenetics; 2003 May; 13(5):265-70. PubMed ID: 12724618
[TBL] [Abstract][Full Text] [Related]
16. Phosphobutyrylcholinesterase: phosphorylation of the esteratic site of butyrylcholinesterase by ethephon [(2-chloroethyl)phosphonic acid] dianion.
Haux JE; Quistad GB; Casida JE
Chem Res Toxicol; 2000 Jul; 13(7):646-51. PubMed ID: 10898597
[TBL] [Abstract][Full Text] [Related]
17. Optimal detection of cholinesterase activity in biological samples: modifications to the standard Ellman's assay.
Dingova D; Leroy J; Check A; Garaj V; Krejci E; Hrabovska A
Anal Biochem; 2014 Oct; 462():67-75. PubMed ID: 24929086
[TBL] [Abstract][Full Text] [Related]
18. The mechanism and benefit of human butyrylcholinesterase activation by what would otherwise be inhibitors.
Stojan J
Chem Biol Interact; 2019 Aug; 308():350-356. PubMed ID: 31173753
[TBL] [Abstract][Full Text] [Related]
19. Bambuterol, a carbamate ester prodrug of terbutaline, as inhibitor of cholinesterases in human blood.
Tunek A; Svensson LA
Drug Metab Dispos; 1988; 16(5):759-64. PubMed ID: 2906603
[TBL] [Abstract][Full Text] [Related]
20. A new perspective on thermal inactivation kinetics of human serum butyrylcholinesterase.
Cengiz D; Cokuğraş AN; Tezcan EF
J Protein Chem; 2002 Mar; 21(3):145-9. PubMed ID: 12018615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
